AI’s Expanded Role in the Life Sciences Regulatory Review Process: Key Developments in U.S. and EU
FDA’s Use of Generative AI in Submission Reviews On May 8, 2025, the FDA Commissioner announced the use of AI in the submission review process across the agency’s centers. According to the FDA’s statement, the agency successfully completed a generative AI pilot program for scientific reviewers that went so well, they are rapidly implementing the […]